Archives: Agenda

• Activities
• Innovations
• International collaborations

• There are many obstacles to running a successful clinical trial – and hospital sites can be one.
• Slow to set up, delays to patient recruitment, or poor data quality?
• TCR-Solutions will share some experience and approaches to troubleshooting these challenges.
• We cannot treat hospital sites like commercial vendors, and we must find a way to work with hospitals to ensure they deliver on time and target.

• New regulations and guidance around running oncology trials in the UK: what do you need to be aware of?
• Running clinical trials in conjunction with the NHS: how to ensure your trial is a success
• Developments in UK cancer research: what’s new in 2025?
• Assessing the impact of political and economic changes on UK oncology trials
• The role of the cancer drug fund in accelerating oncology clinical trials in the UK

• How do we ensure the UK is an attractive location for clinical research
• Navigating new regulations around clinical trials smoothly and successfully
• The impact of artificial intelligence: how far can we expect to move forward in the next 12 months?
• Patient centricity in clinical trials: how can burden be reduced in order to make trials easier for patients to participate in?
• Technological developments in 2025 and beyond: what changes can we expect to see in the next 3-5 years?

• On-demand, remote updates of clinical supply labels — reducing delays and rework
• Integration of digital labels with temperature-controlled shipments to improve visibility and compliance
• Future IoT-enabled clinical supply capabilities to enhance value for patients, sites and sponsors

• Exploring real world applications of AI in route optimization, risk prediction and excursion prevention
• Implementing digital tools for real time monitoring, alerting, and end to end visibility
• Integrating IoT and cloud based systems for smarter, data driven cold chain decisions
• Evaluating readiness and ROI: where does AI and digitisation have the potential to add the most value?
• Overcoming adoption barriers such as cost, data silos, legacy systems and regulatory constraints

MODERATOR

Marco Del Giudice, Co Founder and Vice President, Pharmacom Italia

During the roundtable discussion session, the conference hall will be divided into zones. Delegates can choose which zone they would like to join. Each zone will be led by a table moderator and will focus on a different challenge within supply chain logistics for biopharmaceuticals.

ROUNDTABLE 1: Meeting sustainability targets for pharma supply chains

Kamal Amin, Head of Clinical Supplies Management, Galderma

ROUNDTABLE 2: Managing supply chain vendors to ensure smooth logistical operations

Luiz Barberini, Head of External Manufacturing, Latin America, Bayer

ROUNDTABLE 3: Re-engineering clinical trial supply chains: building faster, smarter and more resilient global operations

Chiara Venuti, Member of the Management Board, Cool Chain Association

ROUNDTABLE 4: Navigating CDMO Partnerships as a Small Biotech: Challenges and Practical Solutions

Amanda Brown, Clinical Trial Supply Manager, Immutep